ATE285408T1 - Paroxetin-n-formyl-derivate - Google Patents
Paroxetin-n-formyl-derivateInfo
- Publication number
- ATE285408T1 ATE285408T1 AT02768169T AT02768169T ATE285408T1 AT E285408 T1 ATE285408 T1 AT E285408T1 AT 02768169 T AT02768169 T AT 02768169T AT 02768169 T AT02768169 T AT 02768169T AT E285408 T1 ATE285408 T1 AT E285408T1
- Authority
- AT
- Austria
- Prior art keywords
- paroxetine
- formyl derivatives
- formyl
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33043001P | 2001-10-22 | 2001-10-22 | |
PCT/NL2002/000654 WO2003044012A1 (en) | 2001-10-22 | 2002-10-15 | N-formyl derivatives of paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE285408T1 true ATE285408T1 (de) | 2005-01-15 |
Family
ID=23289741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02768169T ATE285408T1 (de) | 2001-10-22 | 2002-10-15 | Paroxetin-n-formyl-derivate |
Country Status (15)
Country | Link |
---|---|
US (3) | US6703408B2 (de) |
EP (1) | EP1440067B1 (de) |
AR (1) | AR036860A1 (de) |
AT (1) | ATE285408T1 (de) |
AU (1) | AU2002330771A1 (de) |
CA (1) | CA2464327A1 (de) |
DE (2) | DE20220955U1 (de) |
DK (1) | DK1440067T3 (de) |
ES (1) | ES2230516T3 (de) |
HU (1) | HUP0401895A2 (de) |
IL (1) | IL161521A0 (de) |
NO (1) | NO20042101L (de) |
NZ (1) | NZ532432A (de) |
PT (1) | PT1440067E (de) |
WO (1) | WO2003044012A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6777554B2 (en) | 2001-02-05 | 2004-08-17 | Teva Pharmaceutical Industries Ltd. | Preparation of N-methylparoxetine and related intermediate compounds |
US20060063737A1 (en) * | 2004-08-18 | 2006-03-23 | Holmdahl Lisa K | Liquid paroxetine compositions |
EP1948646A2 (de) * | 2005-11-14 | 2008-07-30 | Auspex Pharmaceuticals Inc. | Substituierte phenylpiperidine mit serotoninerger aktivität und verbesserten therapeutischen eigenschaften |
US9138430B2 (en) * | 2007-12-27 | 2015-09-22 | Mylan Specialty L.P. | Formulation and method for the release of paroxetine in the large intestine |
CN109507349A (zh) * | 2017-09-15 | 2019-03-22 | 万全万特制药江苏有限公司 | 液相色谱法分离测定帕罗西汀中间体光学异构体的方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
EP0223403B1 (de) | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel |
GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
US5856493A (en) * | 1995-02-06 | 1999-01-05 | Smithkline Beecham Corporation | Process for making novel form of paroxeting hydrochloride anhydrate |
JP3446468B2 (ja) | 1996-04-15 | 2003-09-16 | 旭硝子株式会社 | ピペリジンカルビノール類の製造方法 |
EP0812829A1 (de) | 1996-06-14 | 1997-12-17 | Ontogen Corporation | Substituierte Imidazole als Modulatoren für Mehrfachresistenz gegen Medikamente |
JP2002514222A (ja) | 1997-05-29 | 2002-05-14 | スミスクライン・ビーチャム・コーポレイション | 新規方法 |
GB9810181D0 (en) * | 1998-05-13 | 1998-07-08 | Smithkline Beecham Plc | Novel formulations |
CZ20011465A3 (cs) | 1998-11-02 | 2001-08-15 | Synthon B. V. | Způsob přípravy 4-arylpiperidin-3-methanolů a příbuzných sloučenin |
US6239126B1 (en) * | 1998-12-17 | 2001-05-29 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives |
GB9916392D0 (en) | 1999-07-13 | 1999-09-15 | Smithkline Beecham Plc | Novel process |
IT1313702B1 (it) | 1999-08-02 | 2002-09-09 | Chemi Spa | Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine. |
CA2418038A1 (en) * | 2000-08-28 | 2002-03-07 | Synthon B.V. | Paroxetine compositions and processes for making the same |
US6755653B2 (en) * | 2001-10-25 | 2004-06-29 | Cubic Defense Systems, Inc. | System and method for preventing cheating in a simulated combat exercise |
-
2002
- 2002-10-15 PT PT02768169T patent/PT1440067E/pt unknown
- 2002-10-15 AU AU2002330771A patent/AU2002330771A1/en not_active Abandoned
- 2002-10-15 DE DE20220955U patent/DE20220955U1/de not_active Expired - Lifetime
- 2002-10-15 AT AT02768169T patent/ATE285408T1/de not_active IP Right Cessation
- 2002-10-15 DE DE60202381T patent/DE60202381T2/de not_active Expired - Fee Related
- 2002-10-15 ES ES02768169T patent/ES2230516T3/es not_active Expired - Lifetime
- 2002-10-15 CA CA002464327A patent/CA2464327A1/en not_active Abandoned
- 2002-10-15 IL IL16152102A patent/IL161521A0/xx unknown
- 2002-10-15 NZ NZ532432A patent/NZ532432A/en unknown
- 2002-10-15 EP EP02768169A patent/EP1440067B1/de not_active Expired - Lifetime
- 2002-10-15 HU HU0401895A patent/HUP0401895A2/hu unknown
- 2002-10-15 WO PCT/NL2002/000654 patent/WO2003044012A1/en not_active Application Discontinuation
- 2002-10-15 DK DK02768169T patent/DK1440067T3/da active
- 2002-10-21 AR ARP020103949A patent/AR036860A1/es not_active Application Discontinuation
- 2002-10-21 US US10/274,051 patent/US6703408B2/en not_active Expired - Fee Related
-
2004
- 2004-01-20 US US10/759,437 patent/US20040147497A1/en not_active Abandoned
- 2004-01-20 US US10/759,436 patent/US20040266825A1/en not_active Abandoned
- 2004-05-21 NO NO20042101A patent/NO20042101L/no unknown
Also Published As
Publication number | Publication date |
---|---|
DK1440067T3 (da) | 2005-04-11 |
DE60202381T2 (de) | 2005-12-08 |
AU2002330771A1 (en) | 2003-06-10 |
IL161521A0 (en) | 2004-09-27 |
DE60202381D1 (de) | 2005-01-27 |
EP1440067A1 (de) | 2004-07-28 |
ES2230516T3 (es) | 2005-05-01 |
PT1440067E (pt) | 2005-02-28 |
CA2464327A1 (en) | 2003-05-30 |
US20040147497A1 (en) | 2004-07-29 |
DE20220955U1 (de) | 2004-09-02 |
NZ532432A (en) | 2005-02-25 |
US20040266825A1 (en) | 2004-12-30 |
NO20042101L (no) | 2004-05-21 |
AR036860A1 (es) | 2004-10-06 |
US20030125560A1 (en) | 2003-07-03 |
HUP0401895A2 (hu) | 2004-12-28 |
EP1440067B1 (de) | 2004-12-22 |
US6703408B2 (en) | 2004-03-09 |
WO2003044012A1 (en) | 2003-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1515969T3 (da) | Spiroindolinpiperidinderivater | |
ATE319451T1 (de) | Tetrahydrochinolin-derivate | |
DK1556385T3 (da) | Heterocyclocarboxamid-derivater | |
DK1551802T3 (da) | Indol-3-svovlderivater | |
ATE467631T1 (de) | Chinuclidinamidderivate | |
IS7720A (is) | Píperidín-N-oxíð-afleiður | |
ATE438644T1 (de) | Chinazolinderivate | |
DK2248807T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
ATE312827T1 (de) | 3-substituierte-4-pyrimidonderivate | |
ATE308543T1 (de) | Piperidinderivate | |
NO20034970D0 (no) | Nye arylheteroalkylaminderivater | |
DE60307512D1 (de) | 3h-chinazoline -4-on derivaten | |
EE200300447A (et) | Asendatud bensofuraan-2-karboksamiidide derivaadid | |
ATE423771T1 (de) | Tetrahydrochinolinderivate | |
DE60223031D1 (de) | Arylpiperazin gebundene tetrahydroindolonderivate | |
DE50306277D1 (de) | 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate | |
NO20035248D0 (no) | Nye fenylalkyloksy-fenyl derivater | |
ATE382601T1 (de) | Substituierte 4-aminocyclohexanolderivate | |
ATE285408T1 (de) | Paroxetin-n-formyl-derivate | |
DE60200407D1 (de) | Methylendioxy- Derivate | |
ATE299873T1 (de) | Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate | |
IS7906A (is) | Afleiður própargýl-tríflúorómetoxý-amínó-benzóþíazóls | |
IS2431B (is) | Nýjar indólafleiður | |
ATE395327T1 (de) | Amidoacetonitrilderivate | |
DK1503988T3 (da) | Fredericamycin-derivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |